The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction-Reference-Cited by-同舟云学术

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction

Published:2010-12 Issue:12 Volume:12 Page:1309-1316
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Stahrenberg Raoul¹,Edelmann Frank¹,Mende Meinhard²,Kockskämper Anke³,Düngen Hans-Dirk⁴,Lüers Claus¹,Binder Lutz⁵,Herrmann-Lingen Christoph⁶,Gelbrich Götz²,Hasenfuß Gerd¹,Pieske Burkert³,Wachter Rolf¹

Affiliation:

1. Department of Cardiology and Pneumology; University of Goettingen; 37075 Goettingen Germany

2. Coordination Center for Clinical Trials; University of Leipzig; Leipzig Germany

3. Department of Cardiology; Medical University Graz; Graz Austria

4. Department of Cardiology; Charité-Universitätsmedizin; Berlin Germany

5. Department of Clinical Chemistry; University of Goettingen; Goettingen Germany

6. Department of Psychosomatic Medicine; University of Goettingen; Goettingen Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfq151/fullpdf

Reference31 articles.

1. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group;Schocken;Circulation,2008

2. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;N Engl J Med,2006

3. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute;Lee;Circulation,2009

4. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology;Paulus;Eur Heart J,2007

5. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial;Yusuf;Lancet,2003

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease;Biomedicine & Pharmacotherapy;2024-05

2. Prognostic value of growth differentiation factor‐15 in heart failure among whole ejection fraction phenotypes;ESC Heart Failure;2024-04-19

3. Biomarkers of Inflammation in Predicting the Outcomes of Heart Failure of Ischemic Etiology: the Results of Factor Analysis;Kardiologiia;2024-02-29

4. HFpEF: New biomarkers and their diagnostic and prognostic value;Current Problems in Cardiology;2024-01

5. BIOMARKERS OF HEART FAILURE IN PEDIATRIC PRACTICE;Complex Issues of Cardiovascular Diseases;2023-12-25